Comparison of efficacy of low‐carbohydrate and low‐fat diet education programs in non‐alcoholic fatty liver disease: a randomized controlled study (English)
- New search for: Jang, Eun Chul
- New search for: Jun, Dae Won
- New search for: Lee, Seung Min
- New search for: Cho, Yong kyun
- New search for: Ahn, Sang Bong
- New search for: Jang, Eun Chul
- New search for: Jun, Dae Won
- New search for: Lee, Seung Min
- New search for: Cho, Yong kyun
- New search for: Ahn, Sang Bong
In:
HEPATOLOGY RESEARCH
;
48
, 3
;
E22-E29
;
2018
-
ISSN:
- Article (Journal) / Print
-
Title:Comparison of efficacy of low‐carbohydrate and low‐fat diet education programs in non‐alcoholic fatty liver disease: a randomized controlled study
-
Contributors:Jang, Eun Chul ( author ) / Jun, Dae Won ( author ) / Lee, Seung Min ( author ) / Cho, Yong kyun ( author ) / Ahn, Sang Bong ( author )
-
Published in:HEPATOLOGY RESEARCH ; 48, 3 ; E22-E29
-
Publisher:
- New search for: Wiley-Blackwell
-
Publication date:2018-01-01
-
Size:E22-E29
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 48, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- E1
-
Cover, Editorial Board, Table of Contents and Publisher Information| 2018
- E6
-
Are donors or recipients a more important predictive factor for the development of non‐alcoholic fatty liver disease after liver transplantation?Ono, Masafumi et al. | 2018
- E9
-
Serum adrenomedullin and urinary thromboxane B2 help early categorizing of acute kidney injury in decompensated cirrhotic patients: A prospective cohort studyLiu, Chih‐Wei / Huang, Chia‐Chang / Tsai, Hung‐Cheng / Su, Yen‐Bo / Huang, Shiang‐Fen / Lee, Kuei‐Chuan / Hsieh, Yun‐Cheng / Li, Tzu‐Hao / Tsai, Chang‐Youh / Chong, Lee‐Won et al. | 2018
- E22
-
Comparison of efficacy of low‐carbohydrate and low‐fat diet education programs in non‐alcoholic fatty liver disease: A randomized controlled studyJang, Eun Chul / Jun, Dae Won / Lee, Seung Min / Cho, Yong kyun / Ahn, Sang Bong et al. | 2018
- E30
-
Systematic review and meta‐analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non‐alcoholic fatty liver diseaseMurali, Arvind R. / Gupta, Ashutosh / Brown, Kyle et al. | 2018
- E42
-
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver diseaseSeko, Yuya / Sumida, Yoshio / Tanaka, Saiyu / Mori, Kojiroh / Taketani, Hiroyoshi / Ishiba, Hiroshi / Hara, Tasuku / Okajima, Akira / Umemura, Atsushi / Nishikawa, Taichiro et al. | 2018
- E52
-
Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitisTakaya, Hiroaki / Kawaratani, Hideto / Kubo, Takuya / Seki, Kenichiro / Sawada, Yasuhiko / Kaji, Kosuke / Okura, Yasushi / Takeda, Kosuke / Kitade, Mitsuteru / Moriya, Kei et al. | 2018
- E61
-
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin gradeHiraoka, Atsushi / Kumada, Takashi / Hirooka, Masashi / Tsuji, Kunihiko / Itobayashi, Ei / Kariyama, Kazuya / Ishikawa, Toru / Tajiri, Kazuto / Ochi, Hirofumi / Tada, Toshifumi et al. | 2018
- E68
-
Genetic loss of the muscarinic M3 receptor markedly alters bile formation and cholestatic liver injury in miceDurchschein, Franziska / Krones, Elisabeth / Pollheimer, Marion J. / Zollner, Gernot / Wagner, Martin / Raufman, Jean‐Pierre / Fickert, Peter et al. | 2018
- E78
-
Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon–ribavirin‐based therapyHayashi, Kazuhiko / Ishigami, Masatoshi / Yasuda, Satoshi / Ishizu, Yoji / Kuzuya, Teiji / Honda, Takashi / Ishikawa, Tetsuya / Hirooka, Yoshiki / Goto, Hidemi et al. | 2018
- E87
-
Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinomaSaeki, Issei / Yamasaki, Takahiro / Maeda, Masaki / Hisanaga, Takuro / Iwamoto, Takuya / Matsumoto, Toshihiko / Hidaka, Isao / Ishikawa, Tsuyoshi / Takami, Taro / Sakaida, Isao et al. | 2018
- E98
-
Prospective, randomized, controlled study of the efficacy of transcatheter arterial chemoembolization with miriplatin for hepatocellular carcinomaKubota, Kousuke / Hidaka, Hisashi / Nakazawa, Takahide / Okuwaki, Yusuke / Yamane, Keiko / Inoue, Tomoyoshi / Uojima, Haruki / Takada, Juichi / Tanaka, Yoshiaki / Shibuya, Akitaka et al. | 2018
- E107
-
Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double‐blind, controlled trialHidaka, Hisashi / Kokubu, Shigehiro / Sato, Takahiro / Katsushima, Shinji / Izumi, Namiki / Igura, Takumi / Asahara, Shingo / Notsumata, Kazuo / Osaki, Yukio / Tsuji, Keiji et al. | 2018
- E117
-
Renal vein dilation predicts poor outcome in patients with refractory cirrhotic ascitesMatsumoto, Naoki / Ogawa, Masahiro / Kumagawa, Mariko / Watanabe, Yukinobu / Hirayama, Midori / Miura, Takao / Nakagawara, Hiroshi / Matsuoka, Shunichi / Moriyama, Mitsuhiko / Fujikawa, Hirotoshi et al. | 2018
- E126
-
Survival impact of lymphocyte infiltration into the tumor of hepatocellular carcinoma in hepatitis B virus‐positive or non‐B non‐C patients who underwent curative resectionNakagawa, Shigeki / Umezaki, Naoki / Yamao, Takanobu / Kaida, Takayoshi / Okabe, Hirohisa / Mima, Kosuke / Imai, Katsunori / Hashimoto, Daisuke / Yamashita, Yo‐ichi / Ishiko, Takatoshi et al. | 2018
- E133
-
Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near‐normal alanine aminotransferase levelsLi, Jing / Zhang, Tian‐Ying / Song, Liu‐Wei / Qi, Xun / Yu, Xue‐Ping / Li, Fa‐Hong / Zhou, Pu / Qin, Yan‐Li / Yang, Lin / Zhao, Jing‐Hua et al. | 2018
- E146
-
Add‐on effects of fluvastatin in simeprevir/pegylated‐interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled studySuda, Goki / Ito, Jun / Nagasaka, Atsushi / Yamamoto, Yoshiya / Furuya, Ken / Okamoto, Munenori / Terashita, Katsumi / Kobayashi, Tomoe / Tsunematsu, Izumi / Yoshida, Junichi et al. | 2018
- E155
-
Associations between antibody to hepatitis B core antigen positivity and outcomes in hepatocellular carcinoma patients undergoing hepatic resectionItoh, Shinji / Yoshizumi, Tomoharu / Tomino, Takahiro / Nagatsu, Akihisa / Motomura, Takashi / Harada, Noboru / Harimoto, Norifumi / Ikegami, Toru / Soejima, Yuji / Maehara, Yoshihiko et al. | 2018
- E162
-
Effect of PNPLA3 I148M polymorphism on histologically proven non‐alcoholic fatty liver disease in liver transplant recipientsKim, Hyeyoung / Lee, Kwang‐Woong / Lee, Kyoungbun / Seo, Sooin / Park, Min‐Young / Ahn, Sung Woo / Hong, Suk Kyun / Yoon, Kyung Chul / Kim, Hyo‐Sin / Choi, YoungRok et al. | 2018
- E172
-
A seroepidemiological survey of the effect of hepatitis B vaccine and hepatitis B and C virus infections among elementary school students in Siem Reap province, CambodiaFujimoto, Mayumi / Chuon, Channarena / Nagashima, Shintaro / Yamamoto, Chikako / Ko, Ko / Svay, Somana / Hok, Sirany / Lim, Olline / Ohisa, Masayuki / Akita, Tomoyuki et al. | 2018
- E183
-
Clinical significance of half‐lives of tumor markers α‐fetoprotein and des‐γ‐carboxy prothrombin after hepatectomy for hepatocellular carcinomaTsukamoto, Masayo / Nitta, Hidetoshi / Imai, Katsunori / Higashi, Takaaki / Nakagawa, Shigeki / Okabe, Hirohisa / Arima, Kota / Kaida, Takayoshi / Taki, Katsunobu / Hashimoto, Daisuke et al. | 2018
- E194
-
Interleukin‐10 secreted by mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosisWang, Jinglin / Ren, Haozhen / Yuan, Xianwen / Ma, Hucheng / Shi, Xiaolei / Ding, Yitao et al. | 2018
- E203
-
Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virusInoue, Takako / Goto, Takaaki / Iio, Etsuko / Matsunami, Kayoko / Fujiwara, Kei / Shinkai, Noboru / Matsuura, Kentaro / Matsui, Takeshi / Nojiri, Shunsuke / Tanaka, Yasuhito et al. | 2018
- E213
-
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis BYu, Rui / Tan, Deming / Ning, Qin / Niu, Junqi / Bai, Xuefan / Chen, Shijun / Cheng, Jun / Yu, Yanyan / Wang, Hao / Xu, Min et al. | 2018
- E222
-
Risk of malignancies in autoimmune hepatitis type 1 patients with a long‐term follow‐up in JapanArinaga‐Hino, Teruko / Ide, Tatsuya / Miyajima, Ichiro / Ogata, Kei / Kuwahara, Reiichiro / Amano, Keisuke / Kawaguchi, Toshihiro / Nakamura, Toru / Kawaguchi, Takumi / Koga, Hironori et al. | 2018
- E232
-
Hepatitis C virus‐related symptoms, but not quality of life, were improved by treatment with direct‐acting antiviralsIchikawa, Tatsuki / Miyaaki, Hisamitsu / Miuma, Satoshi / Taura, Naota / Motoyoshi, Yasuhide / Akahoshi, Hiroshi / Nakamura, Satomi / Nakamura, Junpei / Takahashi, Youichi / Honda, Tetsurou et al. | 2018
- E240
-
Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatmentAndo, Yusuke / Ishigami, Masatoshi / Ishizu, Yoji / Kuzuya, Teiji / Honda, Takashi / Hayashi, Kazuhiko / Ishikawa, Tetsuya / Nakano, Isao / Hirooka, Yoshiki / Goto, Hidemi et al. | 2018
- E252
-
Prevalence of pruritus in patients with chronic liver disease: A multicenter studyOeda, Satoshi / Takahashi, Hirokazu / Yoshida, Hisako / Ogawa, Yuji / Imajo, Kento / Yoneda, Masato / Koshiyama, Yuichi / Ono, Masafumi / Hyogo, Hideyuki / Kawaguchi, Takumi et al. | 2018
- E263
-
Analysis of hepatitis B surface antigen (HBsAg) using high‐sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assaysOzeki, Itaru / Nakajima, Tomoaki / Suii, Hirokazu / Tatsumi, Ryoji / Yamaguchi, Masakatsu / Kimura, Mutsuumi / Arakawa, Tomohiro / Kuwata, Yasuaki / Ohmura, Takumi / Hige, Shuhei et al. | 2018
- E275
-
Study of the sleep quality and psychological state of patients with hepatitis B liver cirrhosisXiao, Guoqing / Ye, Qing / Han, Tao / Yan, Junqing / Sun, Lixia / Wang, Fengmei et al. | 2018
- E283
-
Changes in serum chitinase 3‐like 1 levels correlate with changes in liver fibrosis measured by two established quantitative methods in chronic hepatitis B patients following antiviral therapyWang, Lin / Liu, Tianhui / Zhou, Jialing / You, Hong / Jia, Jidong et al. | 2018
- E291
-
Pilot study for hepatitis virus screening among employees as an effective approach to encourage employees who screened positive to receive medical care in JapanSugiyama, Aya / Fujii, Toshiko / Nagashima, Shintaro / Ohisa, Masayuki / Yamamoto, Chikako / Chuon, Channarena / Akita, Tomoyuki / Matsuo, Junko / Katayama, Keiko / Takahashi, Kazuaki et al. | 2018
- E303
-
Does the intestinal microenvironment have an impact on the choleretic effect of inchinkoto, a hepatoprotective herbal medicine?Uji, Masahito / Yokoyama, Yukihiro / Asahara, Takashi / Ebata, Tomoki / Igami, Tsuyoshi / Mizuno, Takashi / Yamaguchi, Junpei / Nagino, Masato et al. | 2018
- E311
-
Increased serum C‐reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosisNakai, Masato / Ogawa, Koji / Takeda, Rei / Ohara, Masatsugu / Kawagishi, Naoki / Izumi, Takaaki / Umemura, Machiko / Ito, Jun / Sho, Takuya / Suda, Goki et al. | 2018
- E320
-
Identification of the genomic region under epigenetic regulation during non‐alcoholic fatty liver disease progressionHotta, Kikuko / Kitamoto, Takuya / Kitamoto, Aya / Ogawa, Yuji / Honda, Yasushi / Kessoku, Takaomi / Yoneda, Masato / Imajo, Kento / Tomeno, Wataru / Saito, Satoru et al. | 2018
- E335
-
PNPLA3 as a liver steatosis risk factor following living‐donor liver transplantation for hepatitis CMiyaaki, Hisamitsu / Miuma, Satoshi / Taura, Naota / Shibata, Hidetaka / Soyama, Akihiko / Hidaka, Masaaki / Takatsuki, Mitsuhisa / Eguchi, Susumu / Nakao, Kazuhiko et al. | 2018
- E340
-
Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published worksSegraves, Justin M. / Cartin‐Ceba, Rodrigo / Leise, Michael D. / Krowka, Michael J. et al. | 2018
- E347
-
Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirinSato, Ken / Naganuma, Atsushi / Nagashima, Tamon / Hoshino, Takashi / Uehara, Daisuke / Arai, Yousuke / Horiuchi, Katsuhiko / Yuasa, Kazuhisa / Takayama, Hisashi / Arai, Hirotaka et al. | 2018
- E354
-
Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertensionHiraoka, Atsushi / Kitahata, Shogo / Izumoto, Hirofumi / Ueki, Hidetaro / Aibiki, Toshihiko / Okudaira, Tomonari / Miyamoto, Yuji / Yamago, Hiroka / Iwasaki, Ryuichiro / Tomida, Hideomi et al. | 2018
- E360
-
Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor‐specific anti‐human leukocyte antigen antibody‐mediated rejectionYamada, Yohei / Hoshino, Ken / Mori, Teisaburo / Kawaida, Miho / Abe, Kiyotomo / Ishihama, Hideo / Shimizu, Takahiro / Takahashi, Nobuhiro / Matsubara, Kentaro / Hibi, Taizo et al. | 2018
- E367
-
A severely cholestatic liver graft can be successfully used in deceased donor liver transplantationSakamoto, Seisuke / Sasaki, Kengo / Uchida, Hajime / Narumoto, Soichi / Kitajima, Toshihiro / Irie, Rie / Fukuda, Akinari / Yoshioka, Takako / Kasahara, Mureo et al. | 2018
- E372
-
Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct‐acting antiviralsKurata, Hayato / Uchida, Yoshihito / Kouyama, Jun‐Ichi / Naiki, Kayoko / Nakazawa, Manabu / Ando, Satsuki / Nakao, Masamitsu / Motoya, Daisuke / Sugawara, Kayoko / Inao, Mie et al. | 2018
- E379
-
Comment to “Antithrombin III administration for portal vein thrombosis in patients with liver disease: A randomized double‐blind controlled trial”Blasi, Annabel / Saner, Fuat / Biancofiore, Gianni / Lisman, Ton et al. | 2018
- E381
-
Reply from the authorsHidaka, Hisashi / Kokubu, Shigehiro et al. | 2018